Literature DB >> 26683887

Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.

Stéphan Troyanov1, Catherine Delmas-Frenette2, Guillaume Bollée3, Sonia Youhanna4, Vanessa Bruat5, Philip Awadalla5, Olivier Devuyst6, François Madore2.   

Abstract

BACKGROUND AND OBJECTIVES: The urinary excretion of uromodulin is influenced by common variants in the UMOD gene, and it may be related to NaCl retention and hypertension. Levels of uromodulin are also dependent of the renal function, but other determinants remain unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We tested associations between the urinary excretion of uromodulin; medical history and medication; serum and urinary levels of electrolytes, glucose, and uric acid; and the genotype at the UMOD/Protein Disulfide Isomerase-Like, Testis Expressed locus (rs4293393 and rs12446492); 943 participants from the CARTaGENE Cohort, a random sample from the Canadian population of 20,004 individuals, were analyzed. Participants with available genotyping were obtained from a substudy addressing associations between common variants and cardiovascular disease in paired participants with high and low Framingham risk scores and vascular rigidity indexes.
RESULTS: The population studied was 54±9 years old, with 51% women and eGFR of 9±14 ml/min per 1.73 m(2). Uromodulin excretion was 25 (11-42) mg/g creatinine. Using linear regression, it was independently higher among patients with higher eGFR, the TT genotype of rs4293393, and the TT genotype of rs12446492. The fractional excretions of urate and sodium showed a strong positive correlation with uromodulin, likely linked to the extracellular volume status. The presence of glycosuria and the use of uricosuric drugs, which both increased the fraction excretion of urate, were independently associated with a lower uromodulin excretion, suggesting novel interactions between uric acid and uromodulin excretion.
CONCLUSIONS: In this large cohort, the excretion of uromodulin correlates with clinical, genetic, and urinary factors. The strongest associations were between uric acid, sodium, and uromodulin excretions and are likely linked to the extracellular volume status.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; creatinine; electrolytes; genotype; humans; hypertension; sodium; uric acid; uromodulin

Mesh:

Substances:

Year:  2015        PMID: 26683887      PMCID: PMC4702232          DOI: 10.2215/CJN.04770415

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  45 in total

1.  Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) abundance in the obese Zucker rat.

Authors:  Shahla Riazi; Osman Khan; Swasti Tiwari; Xinqun Hu; Carolyn A Ecelbarger
Journal:  Am J Nephrol       Date:  2006-06-02       Impact factor: 3.754

2.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

3.  Uromodulin storage disease.

Authors:  S H Nasr; J P Lucia; S J Galgano; G S Markowitz; V D D'Agati
Journal:  Kidney Int       Date:  2007-11-14       Impact factor: 10.612

4.  Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner.

Authors:  Kerim Mutig; Thomas Kahl; Turgay Saritas; Michael Godes; Pontus Persson; James Bates; Hajamohideen Raffi; Luca Rampoldi; Shinichi Uchida; Carsten Hille; Carsten Dosche; Satish Kumar; Maria Castañeda-Bueno; Gerardo Gamba; Sebastian Bachmann
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

5.  Uric acid and diabetes: observations in a population study.

Authors:  J B Herman; U Goldbourt
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

6.  Renal effects of Tamm-Horsfall protein (uromodulin) deficiency in mice.

Authors:  Sebastian Bachmann; Kerim Mutig; James Bates; Pia Welker; Beate Geist; Volkmar Gross; Friedrich C Luft; Natalia Alenina; Michael Bader; Bernd J Thiele; Krishna Prasadan; Hajamohideen S Raffi; Satish Kumar
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-02

7.  Renal hypouricaemia in insulin treated diabetes mellitus.

Authors:  A Gotfredsen; P McNair; C Christiansen; I Transbøl
Journal:  Clin Chim Acta       Date:  1982-04-23       Impact factor: 3.786

8.  Determination of uromodulin in human urine: influence of storage and processing.

Authors:  Sonia Youhanna; Julien Weber; Viviane Beaujean; Bob Glaudemans; Jens Sobek; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2013-10-03       Impact factor: 5.992

9.  Uromodulin levels associate with a common UMOD variant and risk for incident CKD.

Authors:  Anna Köttgen; Shih-Jen Hwang; Martin G Larson; Jennifer E Van Eyk; Qin Fu; Emelia J Benjamin; Abbas Dehghan; Nicole L Glazer; W H Linda Kao; Tamara B Harris; Vilmundur Gudnason; Michael G Shlipak; Qiong Yang; Josef Coresh; Daniel Levy; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

10.  SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.

Authors:  Yukihiro Chino; Yoshishige Samukawa; Soichi Sakai; Yasuhiro Nakai; Jun-ichi Yamaguchi; Takeo Nakanishi; Ikumi Tamai
Journal:  Biopharm Drug Dispos       Date:  2014-08-06       Impact factor: 1.627

View more
  11 in total

1.  Tamm Horsfall Glycoprotein and Uromodulin: It Is All about the Tubules!

Authors:  Anthony J Bleyer; Stanislav Kmoch
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 8.237

Review 2.  The UMOD Locus: Insights into the Pathogenesis and Prognosis of Kidney Disease.

Authors:  Olivier Devuyst; Cristian Pattaro
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

3.  Association of Preoperative Urinary Uromodulin with AKI after Cardiac Surgery.

Authors:  Pranav S Garimella; Bertrand L Jaber; Hocine Tighiouart; Orfeas Liangos; Michael R Bennett; Prasad Devarajan; Tarek M El-Achkar; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-26       Impact factor: 8.237

Review 4.  Uromodulin: from physiology to rare and complex kidney disorders.

Authors:  Olivier Devuyst; Eric Olinger; Luca Rampoldi
Journal:  Nat Rev Nephrol       Date:  2017-08-07       Impact factor: 28.314

5.  Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study.

Authors:  Pranav S Garimella; Traci M Bartz; Joachim H Ix; Michel Chonchol; Michael G Shlipak; Prasad Devarajan; Michael R Bennett; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2016-10-28       Impact factor: 8.860

6.  The Uromodulin Gene Locus Shows Evidence of Pathogen Adaptation through Human Evolution.

Authors:  Silvia Ghirotto; Francesca Tassi; Guido Barbujani; Linda Pattini; Caroline Hayward; Peter Vollenweider; Murielle Bochud; Luca Rampoldi; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2016-03-10       Impact factor: 10.121

7.  A novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion.

Authors:  Noel Edwards; Eric Olinger; Jennifer Adam; Michael Kelly; Guglielmo Schiano; Simon A Ramsbottom; Richard Sandford; Olivier Devuyst; John A Sayer
Journal:  Nephrol Dial Transplant       Date:  2017-12-01       Impact factor: 5.992

8.  Uromodulin deficiency alters tubular injury and interstitial inflammation but not fibrosis in experimental obstructive nephropathy.

Authors:  Olena Maydan; Paul G McDade; Yan Liu; Xue-Ru Wu; Douglas G Matsell; Allison A Eddy
Journal:  Physiol Rep       Date:  2018-03

9.  Uromodulin rs4293393 T>C variation is associated with kidney disease in patients with type 2 diabetes.

Authors:  Vinod Kumar; Ashok Kumar Yadav; Vivek Kumar; Anil Bhansali; Vivekanand Jha
Journal:  Indian J Med Res       Date:  2017-11       Impact factor: 2.375

10.  Association of urinary uromodulin with kidney function decline and mortality: the health ABC study
.

Authors:  Pranav S Garimella; Ronit Katz; Joachim H Ix; Linda F Fried; Stephen B Kritchevsky; Prasad Devarajan; Michael R Bennett; Chirag R Parikh; Michael G Shlipak; Tamara B Harris; Orlando M Gutiérrez; Mark J Sarnak
Journal:  Clin Nephrol       Date:  2017-06       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.